[HTML][HTML] A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment
…, SH Ferris, L Kirby, GA Block, CR Lines… - …, 2005 - nature.com
Inflammatory mechanisms have been implicated in Alzheimer's disease (AD) and might be
mediated via the COX-2 enzyme. Previous studies with the selective COX-2 inhibitors, …
mediated via the COX-2 enzyme. Previous studies with the selective COX-2 inhibitors, …
Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone
…, DL Panebianco, M Hesney, CR Lines… - Clinical …, 2003 - Wiley Online Library
Background Aprepitant is a neurokinin 1 receptor antagonist that, in combination with a
corticosteroid and a 5‐hydroxytryptamine 3 receptor antagonist, has been shown to be very …
corticosteroid and a 5‐hydroxytryptamine 3 receptor antagonist, has been shown to be very …
[HTML][HTML] A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
…, DB Rodgers, CL McCormick, M Lee, CR Lines… - BMC Family …, 2002 - Springer
Background Etoricoxib is a highly selective COX-2 inhibitor which was evaluated for the
treatment of rheumatoid arthritis (RA). Methods Double-blind, randomized, placebo and active …
treatment of rheumatoid arthritis (RA). Methods Double-blind, randomized, placebo and active …
A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
…, D Borenstein, PL Zhao, CR Lines… - The Journal of …, 2002 - jrheum.org
OBJECTIVE: To evaluate the efficacy and tolerability of the highly selective cyclooxygenase-2
(COX-2) inhibitor etoricoxib for the treatment of rheumatoid arthritis (RA). METHODS: A …
(COX-2) inhibitor etoricoxib for the treatment of rheumatoid arthritis (RA). METHODS: A …
Randomized, controlled trial of telcagepant over four migraine attacks
…, S Froman, H Leibensperger, CR Lines… - …, 2010 - journals.sagepub.com
Methods: This study evaluated the calcitonin gene-related peptide (CGRP) receptor antagonist
telcagepant (tablet formulation) for treatment of a migraine attack and across four attacks. …
telcagepant (tablet formulation) for treatment of a migraine attack and across four attacks. …
Visual evoked potentials to lateralised stimuli in two cases of callosal agenesis.
MD Rugg, AD Milner, CR Lines - Journal of Neurology, Neurosurgery …, 1985 - jnnp.bmj.com
Visual evoked potentials (VEPs) to lateralised light flashes were recorded from two
acallosal patients. In one patient, these recordings were made while he performed a choice-reaction …
acallosal patients. In one patient, these recordings were made while he performed a choice-reaction …
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
…, D Taraborelli, X Fan, C Assaid, C Lines… - …, 2011 - journals.sagepub.com
Background: This study evaluated the CGRP receptor antagonist MK-3207 for acute treatment
of migraine. Methods: Multicenter, double-blind, randomized, placebo-controlled, parallel-…
of migraine. Methods: Multicenter, double-blind, randomized, placebo-controlled, parallel-…
[HTML][HTML] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
…, B Oxenius, K Horgan, C Lines, R Riddell… - … England Journal of …, 2005 - Mass Medical Soc
Background Selective inhibition of cyclooxygenase-2 (COX-2) may be associated with an
increased risk of thrombotic events, but only limited long-term data have been available for …
increased risk of thrombotic events, but only limited long-term data have been available for …
[CITATION][C] Profilemetrics and facial esthetics
PA Lines, RR Lines, CA Lines - American journal of orthodontics, 1978 - Elsevier
N umerous studies of the relationship between facial profiles and dental occlusion have
appeared in the orthodontic literature. I-’Studies have also been made of orthodontists’ …
appeared in the orthodontic literature. I-’Studies have also been made of orthodontists’ …
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a …
…, X Fan, H Leibensperger, S Froman, C Assaid, C Lines… - The Lancet, 2008 - thelancet.com
Background Calcitonin gene-related peptide (CGRP) probably has a role in migraine
pathophysiology, and antagonism of its receptors might provide treatment without the …
pathophysiology, and antagonism of its receptors might provide treatment without the …